Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer's disease

Brain Research

Volumn 920, Issue 1-2, 2001, Pages 32-40

  Wong, Amanda ^a   Lüth, Hans Joachim ^b   Deuther Conrad, Winnie ^a   Dukic Stefanovic, Sladjana ^a   Gasic Milenkovic, Jovana ^a   Arendt, Thomas ^b   Münch, Gerald ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Amyloid; Advanced glycation endproduct; Alzheimer's disease; Astroglia; Microglia; Nitric oxide synthase

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMYLOID BETA PROTEIN; CYTOKINE; NITRIC OXIDE SYNTHASE;

ADULT; AGE; AGED; ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; ENZYME INDUCTION; ENZYME LOCALIZATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; NERVE CELL; OLFACTORY CORTEX; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TEMPORAL CORTEX;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ENZYME INDUCTION; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; SENILE PLAQUES; TEMPORAL LOBE; TISSUE EMBEDDING;

EID: 0035976590     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(01)02872-4     Document Type: Article

References (52)

1. Inflammation and Alzheimer disease
2. Beta-amyloid stimulation of inducible nitric oxide synthase in astrocytes is interleukin-1beta- and tumor necrosis factor-alpha (TNF alpha)-dependent and involves a TNF alpha receptor-associated factor- and NFkappaB-inducing kinase-dependent signalling mechanism
3. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept
4. The human entorhinal cortex: Normal morphology and lamina specific pathology in various diseases
5. Age, neurofibrillary changes, A-beta-amyloid and the onset of Alzheimer's disease
6. Endogenous nitric oxide synthesis: Biological functions and pathophysiology
7. Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimers disease - Neuropathologic evidence for a mechanism of increased beta-amyloidogenesis
8. Glycation and microglial reaction in lesions of Alzheimer's disease
9. Activation of glial cells by human coronavirus OC43 infection
10. Alterations of synovial tissue and their potential role in the deposition of beta2-microglobulin-associated amyloid
11. Aging, metabolism, and Alzheimer disease - Review and hypotheses
12. Antioxidants, oxidative stress, and degenerative neurological disorders
13. Silver staining of Alzheimer's neurofibrillary changes by means of physical development
14. Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau
15. Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation
16. Beta(2)-microglobulin modified with advanced glycation end products induces interleukin-6 from human macrophages - Role in the pathogenesis of hemodialysis-associated amyloidosis
17. Diagnosis of Alzheimer's disease
18. Interaction of Alzheimer beta-amyloid peptide with the human monocytic cell line THP-1 results in a protein kinase c-dependent secretion of tumor necrosis factor-alpha
19. Inducible nitric oxide synthase (iNOS)-like immunoreactivity in argyrophilic, tau-positive astrocytes in progressive supranuclear palsy
20. Nitric oxide: From discovery to the clinic
21. Peroxinitrite and nitric oxide donors induce neuronal apoptosis by eliciting autocrine excitotoxicity
22. Receptors for advanced glycosylation endproducts in human brain - Role in brain homeostasis
23. Differential expression of advanced glycosylation end-products in neurons of different species
24. A red-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds
25. Expression of type II nitric oxide synthase in primary human astrocytes and microglia: Role of IL-1beta and IL-1 receptor antagonist
26. Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress
27. Oedema extension in cerebral metastasis and correlation with the expression of nitric oxide synthase isozymes (NOS I-III)
28. Oxidative stress in brain ischemia
29. Aberrant expression of nNOS in pyramidal neurons in Alzheimer's disease is highly co-localized with p21 ras and p16INK4a
30. Aging, neurodegenerative disease and the brain
31. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease
32. Selective killing of cholinergic neurons by microglial activation in basal forebrain mixed neuronal/glial cultures
33. Activation of microglial cells by beta-amyloid protein and interferon-gamma
34. Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1
35. The role of oxidative stress and NF-kappaB activation in late diabetic complications
36. Brain glutamate decarboxylase in Parkinson's disease with particular reference to premortem severity index
37. Alzheimer's disease - Synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts
38. Generation of superoxide by purified brain nitric oxide synthase
39. Human immunodeficiency virus infection, inducible nitric oxide synthase expression, and microglial activation: Pathogenetic relationship to the acquired immunodeficiency syndrome dementia complex
40. Widespread peroxynitrite-mediated damage in Alzheimer's disease
41. Oxidative posttranslational modifications in Alzheimer's disease - A possible pathogenic role in the formation of senile plaques and neurofibrillary tangles
42. Nitration and related target interactions of nitric oxide
43. Advanced glycation end products co-localized with astrocytes and microglial cells in Alzheimer's disease brain
44. Immunohistochemical study of advanced glycation end products in aging and Alzheimer's disease brain
45. Glutathione-dependent detoxification of alpha-oxoaldehydes by the glyoxalase system - Involvement in disease mechanisms and antiproliferative activity of glyoxalase I inhibitors
46. Advanced glycation end products contribute to amyloidosis in Alzheimer disease
47. Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease
48. Nitric oxide synthase in reactive astrocytes adjacent to β-amyloid plaques
49. Microglia cells are the driving force in fibrillar plaque formation, whereas astrocytes are a leading factor in plaque degradation
50. Fibrillar beta-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo
51. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins
52. Inducible nitric oxide synthase expression is selectively induced in astrocytes isolated from adult human brain